Literature DB >> 23201069

Analgesic effects of the non-nitrogen-containing bisphosphonates etidronate and clodronate, independent of anti-resorptive effects on bone.

Siyoung Kim1, Masahiro Seiryu, Satoru Okada, Toshinobu Kuroishi, Teruko Takano-Yamamoto, Shunji Sugawara, Yasuo Endo.   

Abstract

Nitrogen-containing bisphosphonates (NBPs) have greater anti-bone-resorptive effects than non-nitrogen-containing bisphosphonates (non-NBPs). Hence, NBPs are the current first-choice drug for osteoporosis. However, NBPs carry a risk of osteonecrosis of jaws. Some animal and human studies suggest that non-NBPs may have anti-bone-resorptive effect-independent analgesic effects, but there has been no detailed comparison between NBPs and non-NBPs. Here, we compared the analgesic effects of several non-NBPs and NBPs, using (a) writhing responses induced in mice by intraperitoneal injection of 1% acetic acid, (b) acetic acid-induced neuronal expression of c-Fos, (c) acetic acid-induced elevation of blood corticosterone, and (d) hindpaw-licking/biting responses induced by intraplantar injection of capsaicin. Among the NBPs and non-NBPs tested, only etidronate and clodronate displayed clear analgesic effects, with various routes of administration (including the oral one) being effective. However, they were ineffective when intraperitoneally injected simultaneously with acetic acid. Intracerebroventricular administration of etidronate or clodronate, but not of minodronate (an NBP), was also effective. The effective doses of etidronate and clodronate were much lower in writhing-high-responder strains of mice. Etidronate and clodronate reduced acetic acid-induced c-Fos expression in the brain and spinal cord, and also the acetic acid-induced corticosterone increase in the blood. Etidronate and clodronate each displayed an analgesic effect in the capsaicin test. Etidronate and clodronate displayed their analgesic effects at doses lower than those inducing anti-bone-resorptive effects. These results suggest that etidronate and clodronate exert potent, anti-bone-resorptive effect-independent analgesic effects, possibly via an interaction with neurons, and that they warrant reappraisal as safe drugs for osteoporosis.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23201069     DOI: 10.1016/j.ejphar.2012.11.031

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  12 in total

Review 1.  The role of drugs in bone pain.

Authors:  Francesco Marras; Paolo Tranquilli Leali
Journal:  Clin Cases Miner Bone Metab       Date:  2016-10-05

2.  Intramuscular clodronate in erosive osteoarthritis of the hand is effective on pain and reduces serum COMP: a randomized pilot trial-The ER.O.D.E. study (ERosive Osteoarthritis and Disodium-clodronate Evaluation).

Authors:  Luca Dalle Carbonare; Gianantonio Saviola; Lul Abdi-Ali; Maria Rosaria Povino; Lorella Campostrini; Silvano Sacco
Journal:  Clin Rheumatol       Date:  2017-05-23       Impact factor: 2.980

Review 3.  Pharmacological options for pain control in patients with vertebral fragility fractures.

Authors:  Nuttan Kantilal Tanna; Terence Ong
Journal:  Osteoporos Sarcopenia       Date:  2022-10-03

4.  Identification of a vesicular ATP release inhibitor for the treatment of neuropathic and inflammatory pain.

Authors:  Yuri Kato; Miki Hiasa; Reiko Ichikawa; Nao Hasuzawa; Atsushi Kadowaki; Ken Iwatsuki; Kazuhiro Shima; Yasuo Endo; Yoshiro Kitahara; Tsuyoshi Inoue; Masatoshi Nomura; Hiroshi Omote; Yoshinori Moriyama; Takaaki Miyaji
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-18       Impact factor: 11.205

Review 5.  Clodronate: new directions of use.

Authors:  Bruno Frediani; Ilaria Bertoldi
Journal:  Clin Cases Miner Bone Metab       Date:  2015-10-26

Review 6.  Pain in Osteoporosis: From Pathophysiology to Therapeutic Approach.

Authors:  Antonino Catalano; Gabriella Martino; Nunziata Morabito; Claudia Scarcella; Agostino Gaudio; Giorgio Basile; Antonino Lasco
Journal:  Drugs Aging       Date:  2017-10       Impact factor: 3.923

7.  Role of intravenous zoledronic acid in management of giant cell tumor of bone- A prospective, randomized, clinical, radiological and electron microscopic analysis.

Authors:  Siddharth Dubey; Shishir Rastogi; Venkatesan Sampath; Shah Alam Khan; Arvind Kumar
Journal:  J Clin Orthop Trauma       Date:  2019-09-28

8.  Effects of etidronate on the Enpp1⁻/⁻ mouse model of generalized arterial calcification of infancy.

Authors:  Carmen Huesa; Katherine A Staines; Jose Luis Millán; Vicky E MacRae
Journal:  Int J Mol Med       Date:  2015-05-15       Impact factor: 4.101

9.  Bisphosphonate use in the horse: what is good and what is not?

Authors:  Alexis Mitchell; Ashlee E Watts; Frank H Ebetino; Larry J Suva
Journal:  BMC Vet Res       Date:  2019-06-24       Impact factor: 2.792

10.  In vitro evidence for the involvement of H2S pathway in the effect of clodronate during inflammatory response.

Authors:  Rosangela Montanaro; Alessio D'Addona; Andrea Izzo; Carlo Ruosi; Vincenzo Brancaleone
Journal:  Sci Rep       Date:  2021-07-20       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.